$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

$nhhs Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000150370721000008 Filed on March 23, 2021

Income Statement

Concept	2020 Q4	2019 Q4	2019 Q3
Revenue	$66.84M	$72.91M	$72.78M
YoY Change	-8.32%		-0.94%
Cost Of Revenue	$46.65M	$46.00M	$45.36M
YoY Change	1.41%		-4.21%
Gross Profit	$20.19M	$26.91M	$27.42M
YoY Change	-24.95%		4.99%
Gross Profit Margin	30.21%	36.9%	37.67%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$16.16M
YoY Change			-36.93%
% of Gross Profit			58.95%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense			$17.22M
YoY Change			-2.6%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income			-$11.64M
YoY Change			-50.01%
Income Tax			$17.00K
% Of Pretax Income
Net Earnings	-$93.54M	-$26.57M	-$14.62M
YoY Change	252.0%	-65.58%	121.44%
Net Earnings / Revenue	-139.94%	-36.45%	-20.09%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	190.2M shares	188.9M shares	189.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q4	2019 Q4	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$66.00M	$41.88M	$29.18M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$21.39M	$21.39M	$21.39M
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$229.2M	$268.9M	$282.6M
YoY Change	-14.77%	1.73%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.918B	$2.141B	$2.173B
YoY Change	-10.4%	-5.44%	-7.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$1.506B	$1.474B	$1.480B
YoY Change	2.22%	-3.05%	-2.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.303B	-$1.041B	-$1.015B
YoY Change	25.11%	8.59%	17.21%
Common Stock	$1.712B	$1.704B	$1.705B
YoY Change	0.46%	0.25%	0.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$409.6M	$662.4M	$687.9M
YoY Change
Total Liabilities & Shareholders Equity	$1.918B	$2.141B	$2.173B
YoY Change	-10.4%	-5.44%	-7.53%

Cashflow Statement

Concept	2020 Q4	2019 Q4	2019 Q3
OPERATING ACTIVITIES
Net Income	-$93.54M	-$26.57M	-$14.62M
YoY Change	252.0%	-65.58%	121.44%
Depreciation, Depletion And Amortization			$16.16M
YoY Change			-36.93%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity Registrant Name EntityRegistrantName	NorthStar Healthcare Income, Inc.
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001503707
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	190837789	shares
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity File Number EntityFileNumber	000-55190
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-3663988
CY2020	dei	City Area Code CityAreaCode	212
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	590 Madison Avenue, 34th Floor
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2020	dei	Local Phone Number LocalPhoneNumber	547-2600
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	0	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	190837789	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65995000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41884000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	27575000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	16936000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1483930000	USD
CY2019Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1700218000	USD
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	229173000	USD
CY2019Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	268894000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	55864000	USD
CY2019Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	55468000	USD
CY2020Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	5000000	USD
CY2019Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	1649000	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	14735000	USD
CY2019Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	13314000	USD
CY2020Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	26483000	USD
CY2019Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	28355000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	9681000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	14489000	USD
CY2020Q4	us-gaap	Assets Assets	1918436000	USD
CY2019Q4	us-gaap	Assets Assets	2141207000	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	1416871000	USD
CY2019Q4	us-gaap	Notes Payable NotesPayable	1431922000	USD
CY2020Q4	nshi	Line Of Credit Related Party LineOfCreditRelatedParty	35000000	USD
CY2019Q4	nshi	Line Of Credit Related Party LineOfCreditRelatedParty	0	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8318000	USD
CY2019Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5780000	USD
CY2020Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	3851000	USD
CY2019Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	3292000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	38393000	USD
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	28135000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	3941000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	4574000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1506374000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	1473703000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	190409341	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	190409341	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	189111561	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	189111561	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1904000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	1891000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1710023000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1702260000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1302755000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1041297000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	467000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-470000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	409639000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	662384000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	2423000	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	5120000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	412062000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	667504000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1918436000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2141207000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	118126000	USD
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	130135000	USD
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	129855000	USD
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	157024000	USD
CY2019	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	161084000	USD
CY2018	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	159481000	USD
CY2020	us-gaap	Other Operating Income OtherOperatingIncome	198000	USD
CY2019	us-gaap	Other Operating Income OtherOperatingIncome	1959000	USD
CY2018	us-gaap	Other Operating Income OtherOperatingIncome	4935000	USD
CY2020	us-gaap	Revenues Revenues	275348000	USD
CY2019	us-gaap	Revenues Revenues	293178000	USD
CY2018	us-gaap	Revenues Revenues	294271000	USD
CY2020	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	7674000	USD
CY2019	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	7703000	USD
CY2018	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	7706000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	5149000	USD
CY2020	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	0	USD
CY2019	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	0	USD
CY2018	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	3824000	USD
CY2020	us-gaap	Investment Income Net InvestmentIncomeNet	7674000	USD
CY2019	us-gaap	Investment Income Net InvestmentIncomeNet	7703000	USD
CY2018	us-gaap	Investment Income Net InvestmentIncomeNet	9031000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	184178000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	181214000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	188761000	USD
CY2020	us-gaap	Interest Expense InterestExpense	65991000	USD
CY2019	us-gaap	Interest Expense InterestExpense	68896000	USD
CY2018	us-gaap	Interest Expense InterestExpense	70196000	USD
CY2020	nshi	Other Expense Securitization Trust OtherExpenseSecuritizationTrust	0	USD
CY2019	nshi	Other Expense Securitization Trust OtherExpenseSecuritizationTrust	0	USD
CY2018	nshi	Other Expense Securitization Trust OtherExpenseSecuritizationTrust	811000	USD
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	65000	USD
CY2019	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	122000	USD
CY2018	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	888000	USD
CY2020	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	17170000	USD
CY2019	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	19789000	USD
CY2018	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	23478000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16505000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12761000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14390000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65006000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	70989000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	107133000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	165968000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	27554000	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	36277000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	514883000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	381325000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	441934000	USD
CY2020	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1840000	USD
CY2019	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2018	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	302000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	6314000	USD
CY2018	us-gaap	Gain Loss On Investments GainLossOnInvestments	20243000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-229719000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-74130000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-118389000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-34466000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3545000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-33517000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	114000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-264238000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-77750000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-152020000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2780000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-790000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-442000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-261458000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-76960000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-151578000	USD
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.38
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.41
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.81
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	189573204	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	189054270	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	187501302	shares
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.03
CY2018	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.34
CY2020	us-gaap	Profit Loss ProfitLoss	-264238000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-77750000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-152020000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	937000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1814000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1968000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	937000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1814000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1968000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-263301000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-75936000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-153988000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2780000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-790000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-442000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-260521000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-75146000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-153546000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	944799000	USD
CY2018	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	9030000	USD
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	174000	USD
CY2018	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	484000	USD
CY2018	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	641000	USD
CY2018	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	25907000	USD
CY2018	us-gaap	Dividends Common Stock DividendsCommonStock	63256000	USD
CY2018	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	33679000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1968000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-152020000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	744374000	USD
CY2019	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	9899000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	239000	USD
CY2019	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	505000	USD
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	294000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	165968000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-152020000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-34466000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3545000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-33517000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65006000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	70989000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	107133000	USD
CY2019	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	10746000	USD
CY2019	us-gaap	Dividends Common Stock DividendsCommonStock	5413000	USD
CY2019	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	4876000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1814000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-77750000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	667504000	USD
CY2020	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	9685000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	169000	USD
CY2020	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	234000	USD
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	151000	USD
CY2020	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	2078000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	937000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-264238000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	412062000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-264238000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-77750000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	27554000	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	36277000	USD
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	222000	USD
CY2019	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	193000	USD
CY2018	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3090000	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3015000	USD
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2932000	USD
CY2020	us-gaap	Straight Line Rent StraightLineRent	-441000	USD
CY2019	us-gaap	Straight Line Rent StraightLineRent	467000	USD
CY2018	us-gaap	Straight Line Rent StraightLineRent	-440000	USD
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	125000	USD
CY2019	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	113000	USD
CY2018	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	101000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1887000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1850000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1946000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	169000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	239000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	174000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	302000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	6314000	USD
CY2018	us-gaap	Gain Loss On Investments GainLossOnInvestments	20243000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2371000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	801000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3172000	USD
CY2020	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	9685000	USD
CY2019	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	9899000	USD
CY2018	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	9030000	USD
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4233000	USD
CY2019	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-691000	USD
CY2018	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-1219000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4859000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	629000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-645000	USD
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	2853000	USD
CY2019	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	204000	USD
CY2018	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	4766000	USD
CY2020	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	559000	USD
CY2019	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	-1087000	USD
CY2018	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	563000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8479000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6647000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2205000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-139000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-675000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	741000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31018000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	25298000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27986000	USD
CY2020	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	15214000	USD
CY2019	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	22323000	USD
CY2018	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	31212000	USD
CY2020	nshi	Proceeds From Sale Of Real Estate Investing ProceedsFromSaleOfRealEstateInvesting	927000	USD
CY2019	nshi	Proceeds From Sale Of Real Estate Investing ProceedsFromSaleOfRealEstateInvesting	19618000	USD
CY2018	nshi	Proceeds From Sale Of Real Estate Investing ProceedsFromSaleOfRealEstateInvesting	11784000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2018	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	35771000	USD
CY2020	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	0	USD
CY2019	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	818000	USD
CY2018	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	0	USD
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2019	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	39801000	USD
CY2018	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	4470000	USD
CY2020	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2019	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2018	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	47813000	USD
CY2020	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Financing Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsFinancingActivities	5923000	USD
CY2019	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Financing Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsFinancingActivities	35922000	USD
CY2018	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Financing Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsFinancingActivities	12672000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	51000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1479000	USD
CY2018	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1590000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8415000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4287000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	73948000	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	12800000	USD
CY2018	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	20250000	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	51734000	USD
CY2018	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	25979000	USD
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	35000000	USD
CY2019	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2018	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	708000	USD
CY2018	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	283000	USD
CY2020	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2019	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2018	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	97000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	608000	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	585000	USD
CY2018	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	610000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2078000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10746000	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25907000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	10813000	USD
CY2018	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	68560000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	4876000	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	33679000	USD
CY2020	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	234000	USD
CY2019	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	505000	USD
CY2018	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	484000	USD
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	151000	USD
CY2019	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	294000	USD
CY2018	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	641000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12147000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-56699000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-87914000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34750000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-35688000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14020000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58820000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94508000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80488000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93570000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58820000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94508000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	53140000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	64163000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	64568000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	10000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	28000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	187000	USD
CY2020	nshi	Distributions Payable DistributionsPayable	0	USD
CY2019	nshi	Distributions Payable DistributionsPayable	0	USD
CY2018	nshi	Distributions Payable DistributionsPayable	5400000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1779000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2378000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1456000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	112000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2018	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	2108000	USD
CY2020	nshi	Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale	5000000	USD
CY2019	nshi	Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale	0	USD
CY2018	nshi	Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale	2183000	USD
CY2020	nshi	Noncash Deconsolidation Variable Interest Entity NoncashDeconsolidationVariableInterestEntity	0	USD
CY2019	nshi	Noncash Deconsolidation Variable Interest Entity NoncashDeconsolidationVariableInterestEntity	0	USD
CY2018	nshi	Noncash Deconsolidation Variable Interest Entity NoncashDeconsolidationVariableInterestEntity	512772000	USD
CY2020	us-gaap	Nature Of Operations NatureOfOperations	Business and Organization<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), was formed to acquire, originate and asset manage a diversified portfolio of equity, debt and securities investments in healthcare real estate, directly or through joint ventures, with a focus on the mid-acuity seniors housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living (“ILF”) facilities and continuing care retirement communities (“CCRC”), which may have independent living, assisted living, skilled nursing and memory care available on one campus. The Company also invests in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Company’s investments are predominantly in the United States, but it also selectively makes international investments. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company conducts its operations so as to continue to qualify as a REIT for U.S. federal income tax purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC (the “Prior Advisor”) and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), each an affiliate of the Company’s sponsor. The Prior Advisor invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of December 31, 2020 and December 31, 2019. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of December 31, 2020, the Company’s limited partnership interest in the Operating Partnership was 99.99%.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is externally managed and has no employees. The Company is sponsored by Colony Capital, Inc. (NYSE: CLNY) (“Colony Capital” or the “Sponsor”), a leading global investment management firm. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Colony Capital manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds and non-traded and traded REITs. The Company’s advisor, CNI NSHC Advisors, LLC (the “Advisor”), is a subsidiary of Colony Capital and manages its day-to-day operations pursuant to an advisory agreement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through December 31, 2020, the Company raised total gross proceeds from the sale of shares of common stock totaling $2.0 billion (the “Offering”), including $232.6 million pursuant to its distribution reinvestment plan (the “DRP”). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time of preparation of this Annual Report on Form 10-K, the world continues to face a global pandemic, the coronavirus 2019 (“COVID-19”). Efforts to address the pandemic continue to significantly impact economic and financial markets globally and across all facets of industries, including real estate. Specifically, the Company's healthcare real estate business and investments have experienced a myriad of challenges, including, but not limited to, declines in resident occupancy and operating cash flows, increases in cost burden faced by operators, lease concessions sought by tenants, and a stressed market affecting real estate values in general. Most of these COVID-19 effects on the Company's business significantly impacted results of operations beginning with the three months ended June 30, 2020, and continued throughout the remainder of the year 2020. At this time, the Company anticipates these effects to be sustained and continue in future periods. While the Company itself has the ability to meet its near term liquidity needs, general market concerns over credit and liquidity continue to permeate in an economic downturn environment. The effects of COVID-19 may also lead to heightened risk of litigation at the investment and corporate level, with an ensuing increase in litigation and related costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a general economic downturn resulting from efforts to contain COVID-19 persists over an extended period of time, this could have a prolonged negative impact on the Company's financial condition and results of operations. At this time, as the extent and </span></div>duration of the increasingly broad effects of COVID-19 on the global economy remain unclear, it is difficult for the Company to assess and estimate the impact on the Company's results of operations with any meaningful precision. Accordingly, any estimates of the effects of COVID-19 as reflected and or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Annual Report on Form 10-K, and such estimates may change, the effects of which could be material. The Company will continue to monitor the progression of COVID-19 and reassess its effects on the Company’s results of operations and recoverability in value across its assets as conditions change.
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000.0	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000.0	shares
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	dei	Entity Number Of Employees EntityNumberOfEmployees	0	employee
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2000000000.0	USD
CY2020	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified on the consolidated statements of cash flows from the supplemental disclosure of non-cash investing and financing activities to adjustments to reconcile net income (loss) to net cash provided by operating activities to conform to current period presentation.</span></div>
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions. Any estimates of the effects of COVID-19 as reflected and or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Annual Report on Form 10-K. Such estimates may change and the impact of which could be material.</span></div>
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65995000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41884000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	73811000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	27575000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	16936000	USD
CY2018Q4	us-gaap	Restricted Cash RestrictedCash	20697000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93570000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58820000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94508000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3500000	USD
CY2019	nshi	Finance Lease Payments FinanceLeasePayments	700000	USD
CY2020	nshi	Finance Lease Payments FinanceLeasePayments	700000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	670000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	59000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	577000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	155000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	17000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	9000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1487000	USD
CY2020Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	112000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1375000	USD
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.062
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2020Q4	nshi	Numberof Properties Heldfor Sale NumberofPropertiesHeldforSale	2	property
CY2019Q4	nshi	Numberof Properties Heldfor Sale NumberofPropertiesHeldforSale	1	property
CY2019Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	28355000	USD
CY2020Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	81000	USD
CY2019Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	151000	USD
CY2020Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	26483000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	4635000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	6437000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	21387000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	21387000	USD
CY2020Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	380000	USD
CY2019Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	380000	USD
CY2020Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	26402000	USD
CY2019Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	28204000	USD
CY2020	nshi	Amortizationof Deferred Costsand Intangible Assets AmortizationofDeferredCostsandIntangibleAssets	1900000	USD
CY2019	nshi	Amortizationof Deferred Costsand Intangible Assets AmortizationofDeferredCostsandIntangibleAssets	8300000	USD
CY2020Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year One DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearOne	1871000	USD
CY2020Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Two DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	593000	USD
CY2020Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Three DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearThree	337000	USD
CY2020Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Four DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFour	337000	USD
CY2020Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Five DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFive	337000	USD
CY2020Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense After Year Five DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1241000	USD
CY2020Q4	nshi	Deferred Costsand Finite Lived Intangible Assets Net DeferredCostsandFiniteLivedIntangibleAssetsNet	4716000	USD
CY2020Q4	nshi	Acquisition Feeand Expense Cap AcquisitionFeeandExpenseCap	0.060
CY2020Q4	nshi	Healthcare Facility Regulatory Reserve HealthcareFacilityRegulatoryReserve	0	USD
CY2019Q4	nshi	Healthcare Facility Regulatory Reserve HealthcareFacilityRegulatoryReserve	6000000	USD
CY2020Q4	nshi	Ownership Interestin Condominiums OwnershipInterestinCondominiums	2327000	USD
CY2019Q4	nshi	Ownership Interestin Condominiums OwnershipInterestinCondominiums	2327000	USD
CY2020Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	3798000	USD
CY2019Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	3841000	USD
CY2020Q4	us-gaap	Lease Incentive Receivable LeaseIncentiveReceivable	2246000	USD
CY2019Q4	us-gaap	Lease Incentive Receivable LeaseIncentiveReceivable	1636000	USD
CY2020Q4	nshi	Utility Deposit Assets UtilityDepositAssets	447000	USD
CY2019Q4	nshi	Utility Deposit Assets UtilityDepositAssets	317000	USD
CY2020Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	863000	USD
CY2019Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	368000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	9681000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	14489000	USD
CY2020Q4	nshi	Lease Terms Days Notice Required For Termination LeaseTermsDaysNoticeRequiredForTermination	30	D
CY2020Q4	nshi	Lease Terms Days Notice Required For Termination LeaseTermsDaysNoticeRequiredForTermination	30	D
CY2020	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	14400000	USD
CY2019	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	16200000	USD
CY2020	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1800000	USD
CY2020	nshi	Lessor Concession Granted Period Covid19 LessorConcessionGrantedPeriodCOVID19	P90D
CY2020	nshi	Lessor Concession Granted Repayment Period Covid19 LessorConcessionGrantedRepaymentPeriodCOVID19	P12M
CY2020Q4	nshi	Lessor Concession Granted Payments Deferred Covid19 LessorConcessionGrantedPaymentsDeferredCOVID19	3900000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	166000000.0	USD
CY2020	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2020	nshi	Impairment Of Affiliate Properties ImpairmentOfAffiliateProperties	38200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	18200000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	114000	USD
CY2020Q4	us-gaap	Land Land	234706000	USD
CY2019Q4	us-gaap	Land Land	236036000	USD
CY2020Q4	us-gaap	Land Improvements LandImprovements	23797000	USD
CY2019Q4	us-gaap	Land Improvements LandImprovements	23287000	USD
CY2020Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1389706000	USD
CY2019Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1551113000	USD
CY2020Q4	us-gaap	Tenant Improvements TenantImprovements	16172000	USD
CY2019Q4	us-gaap	Tenant Improvements TenantImprovements	14642000	USD
CY2020Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2535000	USD
CY2019Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	4956000	USD
CY2020Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	108055000	USD
CY2019Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	100998000	USD
CY2020Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1774971000	USD
CY2019Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1931032000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	291041000	USD
CY2019Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	230814000	USD
CY2020Q4	us-gaap	Real Estate Investments RealEstateInvestments	1483930000	USD
CY2019Q4	us-gaap	Real Estate Investments RealEstateInvestments	1700218000	USD
CY2020	us-gaap	Depreciation Depreciation	63100000	USD
CY2019	us-gaap	Depreciation Depreciation	62800000	USD
CY2018	us-gaap	Depreciation Depreciation	60000000.0	USD
CY2020	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	166000000.0	USD
CY2019	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	27600000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	34183000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	14659000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	10919000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	11192000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	11472000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	45604000	USD
CY2020Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	128029000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	229173000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	268894000	USD
CY2019Q1	nshi	Equity Method Investment Numberof Facilities Sold EquityMethodInvestmentNumberofFacilitiesSold	11	facility
CY2019Q1	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	118000000.0	USD
CY2019Q1	nshi	Proceeds From Sale Of Property Held For Sale Net ProceedsFromSaleOfPropertyHeldForSaleNet	4300000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-34466000	USD
CY2020	nshi	Equity Method Investment Select Revenuesand Expenses Net EquityMethodInvestmentSelectRevenuesandExpensesNet	-74978000	USD
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5923000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3545000	USD
CY2019	nshi	Equity Method Investment Select Revenuesand Expenses Net EquityMethodInvestmentSelectRevenuesandExpensesNet	-40565000	USD
CY2019	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	35922000	USD
CY2019Q1	nshi	Equity Method Investment Numberof Facilities Sold EquityMethodInvestmentNumberofFacilitiesSold	11	facility
CY2019Q1	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	118000000.0	USD
CY2019Q1	nshi	Proceeds From Sale Of Property Held For Sale Net ProceedsFromSaleOfPropertyHeldForSaleNet	4300000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	79696000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	467008000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	19696000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	20406000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	670302000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	178276000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	1435384000	USD
CY2020Q2	nshi	Debt Forbearance Period Maximum DebtForbearancePeriodMaximum	P90D
CY2020Q4	nshi	Debt Instrument Principal Deferred Covid19 DebtInstrumentPrincipalDeferredCOVID19	1300000000	USD
CY2020	nshi	Debt Forbearance Repayment Period DebtForbearanceRepaymentPeriod	P12M
CY2020	nshi	Debt Forbearance Repayment Period DebtForbearanceRepaymentPeriod	P12M
CY2019Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5780000	USD
CY2020	nshi	Related Party Transaction Dueto Related Parties Amount Incurred RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred	31852000	USD
CY2020	nshi	Related Party Transaction Dueto Related Parties Amount Paid RelatedPartyTransactionDuetoRelatedPartiesAmountPaid	29314000	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8318000	USD
CY2020	nshi	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees	9700000	USD
CY2020	nshi	Gain On Settlement Of Share Based Payment GainOnSettlementOfShareBasedPayment	300000	USD
CY2018Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5675000	USD
CY2019	nshi	Related Party Transaction Dueto Related Parties Amount Incurred RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred	31681000	USD
CY2019	nshi	Related Party Transaction Dueto Related Parties Amount Paid RelatedPartyTransactionDuetoRelatedPartiesAmountPaid	31576000	USD
CY2019	nshi	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees	9900000	USD
CY2019	nshi	Gain On Settlement Of Share Based Payment GainOnSettlementOfShareBasedPayment	100000	USD
CY2020	nshi	Stock Redeemedor Called During Period Shares Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodSharesPaymentofAdvisorAssetManagementFees	1600000	shares
CY2020	nshi	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees	9700000	USD
CY2019Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5780000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	200000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	200000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	200000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	200000	USD
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	200000	USD
	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.00184932
	nshi	Common Stock Annualized Distribution CommonStockAnnualizedDistribution	0.675
CY2018	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.000924658
CY2018	nshi	Common Stock Annualized Distribution CommonStockAnnualizedDistribution	0.3375
CY2019Q1	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.000924658
CY2019Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2991000	USD
CY2019Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	2422000	USD
CY2019Q1	us-gaap	Dividends Common Stock DividendsCommonStock	5413000	USD
CY2019Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	0	USD
CY2019Q2	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	0	USD
CY2019Q2	us-gaap	Dividends Common Stock DividendsCommonStock	0	USD
CY2019Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	0	USD
CY2019Q3	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	0	USD
CY2019Q3	us-gaap	Dividends Common Stock DividendsCommonStock	0	USD
CY2019Q4	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	0	USD
CY2019Q4	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	0	USD
CY2019Q4	us-gaap	Dividends Common Stock DividendsCommonStock	0	USD
CY2019	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2991000	USD
CY2019	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	2422000	USD
CY2019	us-gaap	Dividends Common Stock DividendsCommonStock	5413000	USD
CY2018Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	7684000	USD
CY2018Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	7876000	USD
CY2018Q1	us-gaap	Dividends Common Stock DividendsCommonStock	15560000	USD
CY2018Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8028000	USD
CY2018Q2	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	7722000	USD
CY2018Q2	us-gaap	Dividends Common Stock DividendsCommonStock	15750000	USD
CY2018Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8374000	USD
CY2018Q3	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	7567000	USD
CY2018Q3	us-gaap	Dividends Common Stock DividendsCommonStock	15941000	USD
CY2018Q4	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8653000	USD
CY2018Q4	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	7352000	USD
CY2018Q4	us-gaap	Dividends Common Stock DividendsCommonStock	16005000	USD
CY2018	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	32739000	USD
CY2018	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	30517000	USD
CY2018	us-gaap	Dividends Common Stock DividendsCommonStock	63256000	USD
CY2019Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	86000000.0	USD
CY2020	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	300000	shares
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2100000	USD
CY2020	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	6.29
CY2019	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1500000	shares
CY2019	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10700000	USD
CY2019	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	7.10
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2800000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-800000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-400000	USD
CY2020Q4	us-gaap	Revenues Revenues	66841000	USD
CY2020Q3	us-gaap	Revenues Revenues	67755000	USD
CY2020Q2	us-gaap	Revenues Revenues	69308000	USD
CY2020Q1	us-gaap	Revenues Revenues	72891000	USD
CY2020Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1936000	USD
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1927000	USD
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1906000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1905000	USD
CY2020Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	46648000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	46501000	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45328000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45701000	USD
CY2020Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	74531000	USD
CY2020Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	91437000	USD
CY2020Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q4	us-gaap	Costs And Expenses CostsAndExpenses	165333000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	86782000	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	176432000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	86336000	USD
CY2020Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2333000	USD
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1043000	USD
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-34763000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-993000	USD
CY2020Q4	us-gaap	Profit Loss ProfitLoss	-93538000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-18158000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-139995000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-12547000	USD
CY2020Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91709000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17987000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-139281000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12481000	USD
CY2020Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.48
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.74
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2019Q4	us-gaap	Revenues Revenues	72907000	USD
CY2019Q3	us-gaap	Revenues Revenues	72778000	USD
CY2019Q2	us-gaap	Revenues Revenues	74972000	USD
CY2019Q1	us-gaap	Revenues Revenues	72521000	USD
CY2019Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1932000	USD
CY2019Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1946000	USD
CY2019Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1923000	USD
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1902000	USD
CY2019Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	46001000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45359000	USD
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	44636000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45218000	USD
CY2019Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	17408000	USD
CY2019Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10146000	USD
CY2019Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019Q4	us-gaap	Costs And Expenses CostsAndExpenses	106235000	USD
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	86571000	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	95420000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	93099000	USD
CY2019Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4121000	USD
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3037000	USD
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4405000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-224000	USD
CY2019Q4	us-gaap	Profit Loss ProfitLoss	-26924000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-14697000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	-17460000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-18669000	USD
CY2019Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26573000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14624000	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17146000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18617000	USD
CY2019Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	segment
CY2020Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	73	property
CY2020Q4	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	10397	unit
CY2020	us-gaap	Noninterest Income NoninterestIncome	275348000	USD
CY2020	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	275348000	USD
CY2020	us-gaap	Interest Income Operating InterestIncomeOperating	7674000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	184178000	USD
CY2020	us-gaap	Interest Expense InterestExpense	65991000	USD
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	65000	USD
CY2020	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	17170000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16505000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65006000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	165968000	USD
CY2020	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1840000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	302000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-34466000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-264238000	USD
CY2019	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	293178000	USD
CY2019	us-gaap	Interest Income Operating InterestIncomeOperating	7703000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	181214000	USD
CY2019	us-gaap	Interest Expense InterestExpense	68896000	USD
CY2019	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	122000	USD
CY2019	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	19789000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12761000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	70989000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	27554000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	6314000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3545000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-77750000	USD
CY2018	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	294271000	USD
CY2018	us-gaap	Interest Income Operating InterestIncomeOperating	9031000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	188761000	USD
CY2018	us-gaap	Interest Expense InterestExpense	70196000	USD
CY2018	nshi	Other Expense Securitization Trust OtherExpenseSecuritizationTrust	811000	USD
CY2018	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	888000	USD
CY2018	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	23478000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14390000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	107133000	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	36277000	USD
CY2019Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1931032000	USD
CY2018	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	USD
CY2018	us-gaap	Gain Loss On Investments GainLossOnInvestments	20243000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-33517000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	114000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-152020000	USD
CY2020Q4	us-gaap	Assets Assets	1918436000	USD
CY2019Q4	us-gaap	Assets Assets	2141207000	USD
CY2020Q4	srt	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	2200000000	USD
CY2018Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1949997000	USD
CY2017Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1966352000	USD
CY2020	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	0	USD
CY2019	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	16645000	USD
CY2018	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	15240000	USD
CY2020	us-gaap	Real Estate Improvements RealEstateImprovements	17036000	USD
CY2019	us-gaap	Real Estate Improvements RealEstateImprovements	24701000	USD
CY2018	us-gaap	Real Estate Improvements RealEstateImprovements	35889000	USD
CY2020	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	165246000	USD
CY2019	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	27021000	USD
CY2018	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	33494000	USD
CY2020Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Gross Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateGrossIncludingHeldForSale	1782822000	USD
CY2019Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Gross Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateGrossIncludingHeldForSale	1931032000	USD
CY2018Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Gross Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateGrossIncludingHeldForSale	1953507000	USD
CY2020Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateClassifiedAsHeldForSale	7851000	USD
CY2019Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateClassifiedAsHeldForSale	0	USD
CY2018Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateClassifiedAsHeldForSale	3510000	USD
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1774971000	USD
CY2019Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1931032000	USD
CY2018Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1949997000	USD
CY2019Q4	nshi	Sec Schedule Iii Real Estate Amountof Federal Income Tax Basis Over Cost Basis SECScheduleIIIRealEstateAmountofFederalIncomeTaxBasisOverCostBasis	427200000	USD
CY2019Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	230814000	USD
CY2018Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	171083000	USD
CY2017Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	113924000	USD
CY2020	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	63078000	USD
CY2019	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	62798000	USD
CY2018	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	60028000	USD
CY2020	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	0	USD
CY2019	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	3067000	USD
CY2018	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	1542000	USD
CY2020Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationIncludingHeldForSale	293892000	USD
CY2019Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationIncludingHeldForSale	230814000	USD
CY2018Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationIncludingHeldForSale	172410000	USD
CY2020Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationClassifiedAsHeldForSale	2851000	USD
CY2019Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationClassifiedAsHeldForSale	0	USD
CY2018Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationClassifiedAsHeldForSale	1327000	USD
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	291041000	USD
CY2019Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	230814000	USD
CY2018Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	171083000	USD
CY2019Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	55468000	USD
CY2018Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	58600000	USD
CY2017Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	74650000	USD
CY2020	nshi	Sec Schedule1229 Real Estate Companies Investmentin Mortgage Loanson Real Estate Reclassification SECSchedule1229RealEstateCompaniesInvestmentinMortgageLoansonRealEstateReclassification	-271000	USD
CY2019	nshi	Sec Schedule1229 Real Estate Companies Investmentin Mortgage Loanson Real Estate Reclassification SECSchedule1229RealEstateCompaniesInvestmentinMortgageLoansonRealEstateReclassification	2427000	USD
CY2018	nshi	Sec Schedule1229 Real Estate Companies Investmentin Mortgage Loanson Real Estate Reclassification SECSchedule1229RealEstateCompaniesInvestmentinMortgageLoansonRealEstateReclassification	16151000	USD
CY2020	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	0	USD
CY2019	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	818000	USD
CY2018	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	0	USD
CY2020	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	125000	USD
CY2019	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	113000	USD
CY2018	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	101000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	55864000	USD
CY2019Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	55468000	USD
CY2018Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	58600000	USD

Files In Submission

Name	View Source	Status
0001503707-21-000008-index-headers.html	Edgar Link	pending
0001503707-21-000008-index.html	Edgar Link	pending
0001503707-21-000008.txt	Edgar Link	pending
0001503707-21-000008-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nshi-20201231.htm	Edgar Link	pending
nshi-20201231.xsd	Edgar Link	pending
nshi-20201231_cal.xml	Edgar Link	unprocessable
nshi-20201231_def.xml	Edgar Link	unprocessable
nshi-20201231_g1.jpg	Edgar Link	pending
nshi-20201231_g2.jpg	Edgar Link	pending
nshi-20201231_htm.xml	Edgar Link	completed
nshi-20201231_lab.xml	Edgar Link	unprocessable
nshi-20201231_pre.xml	Edgar Link	unprocessable
nshi12312020exhibit211.htm	Edgar Link	pending
nshi12312020exhibit231.htm	Edgar Link	pending
nshi12312020exhibit232.htm	Edgar Link	pending
nshi12312020exhibit233.htm	Edgar Link	pending
nshi12312020exhibit234.htm	Edgar Link	pending
nshi12312020exhibit311.htm	Edgar Link	pending
nshi12312020exhibit312.htm	Edgar Link	pending
nshi12312020exhibit321.htm	Edgar Link	pending
nshi12312020exhibit322.htm	Edgar Link	pending
nshi12312020exhibit42.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

2020 Q4 Form 10-K Financial Statement

#000150370721000008 Filed on March 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS NorthStar Healthcare Income, Inc. Stock $nhhs

2020 Q4 Form 10-K Financial Statement

#000150370721000008 Filed on March 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs